Results of important studies addressing the optimal consolidation regimen and choice and duration of maintenance therapy are eagerly awaited, but it is evident that ASCT is imperative in the treatment of younger patients with multiple myeloma.
Nitya Nathwani, MD
Advertisement
Articles by Nitya Nathwani, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Analyzing ADC Options Across Metastatic TNBC
2
64 A Phase I/II Study of Pembrolizumab and Anti-CD3 x Anti-HER2 Armed Activated T-Cells in Metastatic Breast Cancer
3
Pembrolizumab Combo Shows Efficacy in Pediatric High-Risk Hodgkin Lymphoma
4
CD47 Antibody Combo Shows Meaningful Activity in Previously Untreated AML
5